Presumed Central Serous Retinopathy Due to Sertraline (Sertraline Retinopathy)

Objective & Hypothesis:A 36 year-old male patient who developed central serous retinop- athy (CSR) presumed to result from intake of sertraline hydro- chloride (100 mg per day) during one year.

📊

Key Findings & Data:A complete ocular examination, color vision testing, automated static perimetry, optical coherence tomography (OCT) and fun- dus fl uorescein angiography (FFA) were performed.

💡

Conclusion & Impact:In conclussion, the patients who use sertralin should be aware of the potential risk of developing CSR or the other macular changes.

🔬Design:Research Article

📍Scope:Comprehensive Sample

⚙️Variables:Domain Parameters

Özet

A 36 year-old male patient who developed central serous retinop- athy (CSR) presumed to result from intake of sertraline hydro- chloride (100 mg per day) during one year. A complete ocular examination, color vision testing, automated static perimetry, optical coherence tomography (OCT) and fun- dus fl uorescein angiography (FFA) were performed. OCT and FFA fi ndings were revealed a central serous retinopathy in the right eye in a patient who use sertraline for more than a year. In conclussion, the patients who use sertralin should be aware of the potential risk of developing CSR or the other macular changes.

🔖

Cite This Article

CUMURCU, T., CUMURCU, B. E., ZAYMAN, E. P., ÇAVDAR, M., NURLU, K., DOĞANAY, S. (2017). Presumed Central Serous Retinopathy Due to Sertraline (Sertraline Retinopathy). Retina-Vitreus, Cilt: 26 - Sayı: 0, 269–271. https://ajindex.com/articles/304869

References (3)

Budavari S (1989): The Merck Index, 11th edition. p 1342. Rah- way, Merck and Co. Inc, Carrasco JL, Sandner C. Clinical eff ects of pharmacological vari- ations in selective serotonin reuptake inhibitors: an overview. Int J CIin Pract 2005; 59: 1428-1434.
Dewan MJ, Anand VS. Evaluating the tolerability of the newer antidepressants. J Nerv Ment Dis. 1999; 187: 96-101. Sener EC and Kiratli H. Presumed sertraline maculopathy. Acta Ophthalmol Scand 2001: 79: 428–430. Mason JO 3rd and Patel SA. Bull’S eye maculopathy in a patient taking sertraline. Retin Cases Brief Rep. 2015; 9(2):131-3. Barret J. Anisocoria associated with selective serotonin reuptake inhibitors. Br Med J 1994; 309: 1620. Bourgeois JA, Thomas D, Johansen T, Walker DM. Visual hallu- cinations associated with fl uoxetine and sertraline. J Clin Psy- chopharmacol 1998; 18: 482–483. Lehman NL and Johnson LN. Toxic optic neuropathy after con- comitant use of melatonin, zoloft and a high-protein diet. J Neu- ro-Ophthalmol 1999; 19: 232–234.
Van Cann EM, Koole R. Retrobulbar hematoma associated with selective serotonin reuptake inhibitor: a case report.Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009;108: 1-2.